Luna, G., Alping, P., Burman, J., Fink, K., Fogdell-Hahn, A., Gunnarsson, M., . . . Frisell, T. (2019). Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies. JAMA Neurol.
Styl cytowania ChicagoLuna, Gustavo, et al. "Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies." JAMA Neurol 2019.
Styl cytowania MLALuna, Gustavo, et al. "Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies." JAMA Neurol 2019.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..